Navigation Links
Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study

earance (results were, respectively, 17 percent, 53 percent, 63 percent, 77 percent, 53 percent, vs. 0 percent of those receiving placebo; p<0.001 for all groups except the single-dose group, 200mg at week 0).

The most common adverse events observed were injection site reactions, nasopharyngitis (inflammation of the nose and pharynx), upper respiratory infections and headache.

"We're very excited about these promising Phase II results," said Eugene Sun, M.D., vice president, Global Pharmaceutical Clinical Development at Abbott. "In all but one of the dosing groups in this study, at least 90 percent of patients showed significant improvement, and many experienced almost complete clearance. We look forward to studying ABT-874 further."

Abbott's Commitment to Immunology

Abbott is focused on the discovery and development of innovative treatments for immunologic diseases. The Abbott Bioresearch Center, founded in 1989 in Worcester, Mass., United States, is a world-class discovery and basic research facility supporting research and development of biologic treatments. Abbott Biotechnology Limited, which opened earlier this year in Barceloneta, Puerto Rico, United States, is the main production facility for Abbott's anti-TNF treatment and one of the world's largest centers for production of monoclonal antibodies.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com.

CONTACT: U.S. Media, Liz Shea, +1-847-935-2211, or International Media,Tracy Sorrentino, +1-847-937-8712, or Financial, John Thomas,+1-847-938-26
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
2. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
3. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
6. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
7. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
8. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
9. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
10. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
11. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting

Post Your Comments:
(Date:11/30/2009)...0 Decision Resources, one of the w...g on pharmaceutical and healthcare issues, forecas...a will grow nine percent annually over the 2008 - ...This growth will be driven mainly by increased gov...f more-expensive therapies like pegylated interfer...
(Date:11/30/2009)...ewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, ...ompany") a growing developer and,producer of presc...maceutical,products in the People,s Republic of Ch...ter Drug division ("OTC Division") successfully en...ndred drug stores in Beijing as of,today. The Comp...
(Date:11/30/2009)...ewswire/ -- Intelliject, Inc. today announced an e...vel epinephrine auto-injector, in the U.S. and Can....S. shall be responsible for manufacturing and com...r the on-going development and for obtaining U.S. ...omotion rights in the territory. ,, Sanofi-aven...
Breaking Medicine Technology:Russia's Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013 2Russia's Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013 3Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores 2Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores 3Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 2Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 3The Hispanic got milk 3F Campaign Visited New York July 18 July 22 52678 1The Hispanic got milk 3F Campaign Visited New York July 18 July 22 52678 2Breast cancer research highlights from the American Association of Physicists in Medicine meeting in Anaheim July 26 30 52673 1Breast cancer research highlights from the American Association of Physicists in Medicine meeting in Anaheim July 26 30 52673 2Breast cancer research highlights from the American Association of Physicists in Medicine meeting in Anaheim July 26 30 52673 3Breast cancer research highlights from the American Association of Physicists in Medicine meeting in Anaheim July 26 30 52673 4Breast cancer research highlights from the American Association of Physicists in Medicine meeting in Anaheim July 26 30 52673 5In vitro antibody production enables HIV infection detection in window period key to safer blood 9347 1In vitro antibody production enables HIV infection detection in window period key to safer blood 9347 2
..., Dec. 27 According to the latest,science, resver...t doses of,resveratrol plus an array of antioxidan...s of aged, red wine, rather than resveratrol alone...rnh/20080603/LATU039 ) , The most recent stud...ng,the life of laboratory mice. In fact, mega-dos...
...omplex of Its Kind; 80 Percent of Trauma Patient,s...multi-disciplinary team of doctors and surgeons at...r-total face transplant in the United States. , ... past two weeks, surgeons transplanted 80 percent ...a -- essentially replacing her entire face, except...
Other Medicine Technology:Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 3Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant 2Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant 3
(Date:11/30/2009)... ,stroke belt, study finds , , MONDA..."stroke belt" of the southern United States have a...rs, even if they live elsewhere later, a new study...orn in the North and South Carolina, Georgia, Tenn...nsistently higher incidence of stroke compared to ...
(Date:11/30/2009)...s than sedentary, healthy adults , , , ...hown that exercise can help ward off heart disease...eason why may be found within cells themselves. ,...A at the tips of chromosomes that protect the cell...oking adults who did not exercise regularly, Germa...
(Date:11/30/2009)...-USNewswire/ -- SEIU Local 21LA members and New Or...ill hold a rally Tuesday, Dec. 1, 2009, at noon at...800 Desire Parkway, New Orleans, to protest an unr...policies that target employees who are ill or who ...oyees who clean schools in the Recovery School Dis...
(Date:11/30/2009)... 30 A new poll released today ...ation Center for Health Policy at the University o...ows a widespread consensus among the Latino/Hispan...eform and indicates significant support for expans...ops the list of national issues identified by resp...
(Date:11/30/2009)...30 Tyco International Lt...nual general meeting of shareholders will be held ...European time at the Park Hyatt Zurich Hotel, Beet...ered shareholders as of January 11, 2010 (the reco...neral meeting. Additionally, individuals who requ...
Breaking Medicine News(10 mins):Health News:Birth in South Raises Stroke Risk for Life 2Health News:Birth in South Raises Stroke Risk for Life 3Health News:Exercise Guards White Blood Cells Against Aging 2Health News:Exercise Guards White Blood Cells Against Aging 3Health News:As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness 2Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 2Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 3Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 4Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 5Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 6Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 7Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 8Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 9
...ical Center this week launched an International St...adult and embryonic stem cell research. // Th...al of renowned Israeli developmental geneticist Ni...dars-Sinai. “This is the time, this is the p...
...of the University of Queensland carried out an inv...sbane. They reported that Spray –on skin //is effe... “Microskin” is the product that not only faded...in technology, adheres to the epidermis. One appl...
...t of female German smokers refuse to quit smoking ... by the Instituts Gewis for the Hamburg-based maga...9 percent of those between ages 25 and 39 replied,...ntre in Heidelberg. However, they only gain ...
...model has been developed by researchers at the Vir...ech which would allow scientists to have a better ...the HIV/AIDS drug zidovudine (azidothymidine, AZT)...V-infected individuals. However, long-term use of ...
... disclosed the mechanism by which environmental st... affirming that increased mental and physical acti...to this effect presented by Ambrée et al., "Redu...issue of The American Journal of Pathology. ...
...als have issued serious warnings against the use o...ide which are sold online//. These products a... hydrogen peroxide products are highly corrosive a... would result in blood vessel inflammation, bubble...
Other Medicine News:Health News:Center Launches New International Stem Cell Research Institute 2Health News:Computational Model Reveals Working of AZT in Body 2Health News:Active Life Decelerates Alzheimer's 2
...he FR-20 Frame Reader with the added benefit of re...he frame reader to the edger in use! The FR-20M is...er in a seperate location, allowing you to streaml...ta along with the patient's prescription, includin...
... system enhances clinical evaluations with the out...he system offers an enlarged color map, tangential...etric data, and peripheral keratometric maps. It p...oconus as well as pre and post-op evaluation. The ...
...accurate, and reliable tests of a wide variety of ... conditions for viewing far point test charts at 5...nt test charts at 30cm (12"). The SS-3, which is v...at can be interchanged as required. The tests show...
Topcon OM-4 Ophthalmometer
Medicine Products: